Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TC-2153 is a selective inhibitor of striatal-enriched protein tyrosine phosphatase (STEP), exhibiting psychotropic activity and low acute toxicity. This compound not only enhances the expression of brain-derived neurotropic factor (BDNF) in the brain but also reduces the mRNA levels of MAOA and 5-HT1A receptors in the midbrain. Additionally, TC-2153 inhibits 5-HT2A receptor-mediated signaling.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | TC-2153 is a selective inhibitor of striatal-enriched protein tyrosine phosphatase (STEP), exhibiting psychotropic activity and low acute toxicity. This compound not only enhances the expression of brain-derived neurotropic factor (BDNF) in the brain but also reduces the mRNA levels of MAOA and 5-HT1A receptors in the midbrain. Additionally, TC-2153 inhibits 5-HT2A receptor-mediated signaling. |
Molecular Weight | 355.89 |
Formula | C7H5ClF3NS5 |
CAS No. | 1381769-23-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TC-2153 1381769-23-8 MK-8825 MK8825 TC 2153 TC2153 inhibitor inhibit